Keywords: teva, posts, equivocal, data, oral, copaxone, update

Teva posts equivocal data on oral Copaxone - UPDATE

Article | 20 September 2001

Print This

Teva Pharmaceutical Industries has reported that an interim analysis ofits trial of an oral formulation of its injectable multiple sclerosis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in